FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2755989812> ?p ?o ?g. }

• W2755989812 endingPage "84085" @default.
• W2755989812 startingPage "84074" @default.
• W2755989812 abstract "// Emiliano Fabiani 1, * , Giulia Falconi 1, * , Nélida Inés Noguera 1, 2 , Ernestina Saulle 3 , Laura Cicconi 1 , Mariadomenica Divona 1 , Cristina Banella 2 , Alessandra Picardi 1 , Anna Maria Cerio 4 , Letizia Boe 5 , Massimo Sanchez 5 , Elvira Pelosi 4 , Ugo Testa 4 , Francesco Lo-Coco 1, 2 and Maria Teresa Voso 1 1 Università di Roma Tor Vergata, Dipartimento di Biomedicina e Prevenzione, Rome, Italy 2 Fondazione Santa Lucia, Laboratorio di Neuro-Oncoematologia, Rome, Italy 3 Istituto Superiore di Sanità, Centro Nazionale per la Ricerca e la Valutazione Preclinica e Clinica dei Farmaci, Rome, Italy 4 Istituto Superiore di Sanità, Dipartimento di Ematologia ed Oncologia, Rome, Italy 5 Istituto Superiore di Sanità, Grandi Strumentazioni e Core Facilities, Rome, Italy * These authors contributed equally to this work Correspondence to: Maria Teresa Voso, email: voso@med.uniroma2.it Keywords: acute promyelocytic leukemia, forkhead box C1, ATRA, decitabine, epigenetic regulation Received: April 27, 2017      Accepted: August 31, 2017      Published: September 20, 2017 ABSTRACT Forkhead box (FOX) genes encode transcription factors, which regulate embryogenesis and play an important role in hematopoietic differentiation and in mesenchymal niche maintenance. Overexpression of the family member FOXC1 has been reported in solid tumors and acute myeloid leukemia (AML). We studied FOXC1 expression and function in acute promyelocytic leukemia (APL) and normal hematopoietic progenitors. FOXC1 mRNA and protein levels were significantly lower in primary marrow samples from 27 APL patients, as compared to samples obtained from 27 patients with other AML subtypes, and 5 normal CD34+ hematopoietic cells. FOXC1 expression significantly increased in APL samples at the time of remission following consolidation treatment. In cell lines overexpressing PML-RARA, and in the NB4 t(15;17)-positive cell line, FOXC1 expression was lower than in other non-APL cell lines, and increased following treatment with all-trans retinoic acid (ATRA), due to functional binding of ATRA to the FOXC1 promoter region. Reduced FOXC1 expression was also associated to DNA hypermethylation of the +354 to +568 FOXC1 region, both in primary APL, and in NB4 cells. Treatment of NB4 cells with decitabine demethylated FOXC1 and upregulated its expression. Our findings indicate that FOXC1 is consistently repressed in APL due to hypermethylation and the presence of the PML-RARA rearrangement. A potential role of hypomethylating treatment in advanced APL remains to be established." @default.
• W2755989812 created "2017-09-25" @default.
• W2755989812 creator A5002968095 @default.
• W2755989812 creator A5008684425 @default.
• W2755989812 creator A5013855942 @default.
• W2755989812 creator A5017743088 @default.
• W2755989812 creator A5024783703 @default.
• W2755989812 creator A5041803804 @default.
• W2755989812 creator A5054876863 @default.
• W2755989812 creator A5055619996 @default.
• W2755989812 creator A5063111161 @default.
• W2755989812 creator A5071136269 @default.
• W2755989812 creator A5071933116 @default.
• W2755989812 creator A5074404662 @default.
• W2755989812 creator A5085307562 @default.
• W2755989812 creator A5087863588 @default.
• W2755989812 creator A5088682221 @default.
• W2755989812 date "2017-09-20" @default.
• W2755989812 modified "2023-10-16" @default.
• W2755989812 title "The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia" @default.
• W2755989812 cites W1531493896 @default.
• W2755989812 cites W1600841976 @default.
• W2755989812 cites W1752169014 @default.
• W2755989812 cites W1933629402 @default.
• W2755989812 cites W1969415039 @default.
• W2755989812 cites W1980587308 @default.
• W2755989812 cites W1987061720 @default.
• W2755989812 cites W1992623092 @default.
• W2755989812 cites W2010216204 @default.
• W2755989812 cites W2080533166 @default.
• W2755989812 cites W2083557513 @default.
• W2755989812 cites W2091005907 @default.
• W2755989812 cites W2096638244 @default.
• W2755989812 cites W2096996041 @default.
• W2755989812 cites W2104178560 @default.
• W2755989812 cites W2122952132 @default.
• W2755989812 cites W2129338773 @default.
• W2755989812 cites W2129873144 @default.
• W2755989812 cites W2152558791 @default.
• W2755989812 cites W2155706733 @default.
• W2755989812 cites W2163107106 @default.
• W2755989812 cites W2164508407 @default.
• W2755989812 cites W2351209969 @default.
• W2755989812 cites W2426586472 @default.
• W2755989812 cites W2510638715 @default.
• W2755989812 cites W2511021411 @default.
• W2755989812 doi "https://doi.org/10.18632/oncotarget.21101" @default.
• W2755989812 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5663578" @default.
• W2755989812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29137406" @default.
• W2755989812 hasPublicationYear "2017" @default.
• W2755989812 type Work @default.
• W2755989812 sameAs 2755989812 @default.
• W2755989812 citedByCount "4" @default.
• W2755989812 countsByYear W27559898122019 @default.
• W2755989812 crossrefType "journal-article" @default.
• W2755989812 hasAuthorship W2755989812A5002968095 @default.
• W2755989812 hasAuthorship W2755989812A5008684425 @default.
• W2755989812 hasAuthorship W2755989812A5013855942 @default.
• W2755989812 hasAuthorship W2755989812A5017743088 @default.
• W2755989812 hasAuthorship W2755989812A5024783703 @default.
• W2755989812 hasAuthorship W2755989812A5041803804 @default.
• W2755989812 hasAuthorship W2755989812A5054876863 @default.
• W2755989812 hasAuthorship W2755989812A5055619996 @default.
• W2755989812 hasAuthorship W2755989812A5063111161 @default.
• W2755989812 hasAuthorship W2755989812A5071136269 @default.
• W2755989812 hasAuthorship W2755989812A5071933116 @default.
• W2755989812 hasAuthorship W2755989812A5074404662 @default.
• W2755989812 hasAuthorship W2755989812A5085307562 @default.
• W2755989812 hasAuthorship W2755989812A5087863588 @default.
• W2755989812 hasAuthorship W2755989812A5088682221 @default.
• W2755989812 hasBestOaLocation W27559898121 @default.
• W2755989812 hasConcept C104317684 @default.
• W2755989812 hasConcept C143998085 @default.
• W2755989812 hasConcept C150194340 @default.
• W2755989812 hasConcept C190727270 @default.
• W2755989812 hasConcept C203014093 @default.
• W2755989812 hasConcept C2776601000 @default.
• W2755989812 hasConcept C2778461978 @default.
• W2755989812 hasConcept C2778729363 @default.
• W2755989812 hasConcept C2780235182 @default.
• W2755989812 hasConcept C2781121885 @default.
• W2755989812 hasConcept C41091548 @default.
• W2755989812 hasConcept C502942594 @default.
• W2755989812 hasConcept C54355233 @default.
• W2755989812 hasConcept C71924100 @default.
• W2755989812 hasConcept C81885089 @default.
• W2755989812 hasConcept C86339819 @default.
• W2755989812 hasConcept C86803240 @default.
• W2755989812 hasConceptScore W2755989812C104317684 @default.
• W2755989812 hasConceptScore W2755989812C143998085 @default.
• W2755989812 hasConceptScore W2755989812C150194340 @default.
• W2755989812 hasConceptScore W2755989812C190727270 @default.
• W2755989812 hasConceptScore W2755989812C203014093 @default.
• W2755989812 hasConceptScore W2755989812C2776601000 @default.
• W2755989812 hasConceptScore W2755989812C2778461978 @default.
• W2755989812 hasConceptScore W2755989812C2778729363 @default.
• W2755989812 hasConceptScore W2755989812C2780235182 @default.
• W2755989812 hasConceptScore W2755989812C2781121885 @default.

• next